Cargando…
Magnetic seizure therapy and electroconvulsive therapy increase aperiodic activity
Major depressive disorder (MDD) is a leading cause of disability worldwide. One of the most efficacious treatments for treatment-resistant MDD is electroconvulsive therapy (ECT). Recently, magnetic seizure therapy (MST) was developed as an alternative to ECT due to its more favorable side effect pro...
Autores principales: | Smith, Sydney E., Kosik, Eena L., van Engen, Quirine, Kohn, Jordan, Hill, Aron T., Zomorrodi, Reza, Blumberger, Daniel M., Daskalakis, Zafiris J., Hadas, Itay, Voytek, Bradley |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10651875/ https://www.ncbi.nlm.nih.gov/pubmed/37968260 http://dx.doi.org/10.1038/s41398-023-02631-y |
Ejemplares similares
-
Magnetic seizure therapy and electroconvulsive therapy increase aperiodic activity
por: Smith, Sydney E., et al.
Publicado: (2023) -
Modulation of functional network properties in major depressive disorder following electroconvulsive therapy (ECT): a resting-state EEG analysis
por: Hill, Aron T., et al.
Publicado: (2020) -
Clinical EEG slowing induced by electroconvulsive therapy is better described by increased frontal aperiodic activity
por: Smith, Sydney E., et al.
Publicado: (2023) -
Subgenual cingulate connectivity and hippocampal activation are related to MST therapeutic and adverse effects
por: Hadas, Itay, et al.
Publicado: (2020) -
Confirmatory Efficacy and Safety Trial of Magnetic Seizure Therapy for Depression (CREST-MST): protocol for identification of novel biomarkers via neurophysiology
por: Daskalakis, Zafiris J., et al.
Publicado: (2021)